Advances in oncolytic virus therapy for glioma. - Wikidata - awgldk - TriplyDB

Advances in oncolytic virus therapy for glioma.

Advances in oncolytic virus therapy for glioma.

http://www.wikidata.org/entity/Q37287118

about

Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma.Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1.Impact of tumor microenvironment on oncolytic viral therapy Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.Gene therapy for malignant glioma.The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus.Strategies in gene therapy for glioblastoma."Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.HSV Recombinant Vectors for Gene Therapy.Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma.Advance in herpes simplex viruses for cancer therapy.Clinical trials of viral therapy for malignant gliomas.Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme.Equine herpesvirus type 1-mediated oncolysis of human glioblastoma multiforme cells.The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo.Viability reduction and Rac1 gene downregulation of heterogeneous ex-vivo glioma acute slice infected by the oncolytic Newcastle disease virus strain V4UPM Effects of CCN1 and Macrophage Content on Glioma Virotherapy: A Mathematical Model.Oncolytic Herpes Simplex Virus Glioblastoma Therapy is Potentiated by Tumor Necrosis Factor-α Inhibition.Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer.Ral signaling pathway in health and cancer.Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma.

P2860

Q26996081-AFEF3444-A651-41D6-BFBB-00FC79530816 Q30809060-A0DE3531-9DDF-4DDE-B5C7-B2DDA89A43E0 Q33638847-A3237514-E7DB-46C4-86D7-78C86194E864 Q33895533-A0ECD5EE-0E63-48AD-9127-E8819F1F2D06 Q34715771-8B161EC5-1B87-4D59-AAC3-C38373777719 Q35210355-F32D6939-3F98-4368-8A53-192E1B1326CD Q35238250-CD59D408-9DC9-458B-AC5B-9A8BA1A6E8B7 Q35522211-D3320D9D-66DE-4336-B6ED-25E12C57EA6D Q35673628-57D97A27-5197-4CA2-95B0-617B78DE7515 Q36887446-54ABCA72-3E5B-490C-918F-0904E37E950C Q37420576-BE5F2035-392E-4905-B3BF-5D2A320DD07A Q37622288-0B419450-09B3-44D4-9B3C-006DD01BBB6E Q37787777-F8FB1D0F-ABBE-46D4-865C-B3CC72246B8D Q37818222-2A6831BF-9548-43F9-BAB8-9DF960E97D9D Q38096940-24E7660E-AA35-472F-B27C-393FCE04A044 Q38153777-5DA32B88-39AF-4A56-8FCB-1A9CFACA4257 Q38253056-CEEA2D99-9C75-4A21-A714-EAE55B4AE0CA Q39420986-DD0E9BB7-AC92-4064-ADD4-608264B45B43 Q39537474-943670A8-3B38-41E9-99CD-944BA6F001A9 Q41976320-C5479754-1423-4F46-9FD0-7FD37523C8CC Q42155868-942BD1B7-02F9-43E0-A26A-065EAB430959 Q45341348-FC129BE7-FD48-41FD-8BF3-30DF37836E6B Q45360866-75E651A5-2248-4CE1-890F-4F60534D11FD Q47124416-F6C3902F-412B-4124-BBFE-CC169B0DB4EB Q47141309-0E8CF574-8F4B-4918-9943-3574358B2BC8

P2860

Advances in oncolytic virus therapy for glioma.

http://www.wikidata.org/entity/Q37287118

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Advances in oncolytic virus therapy for glioma.

@en

Advances in oncolytic virus therapy for glioma.

@nl

type

label

Advances in oncolytic virus therapy for glioma.

@en

Advances in oncolytic virus therapy for glioma.

@nl

prefLabel

Advances in oncolytic virus therapy for glioma.

@en

Advances in oncolytic virus therapy for glioma.

@nl

P1433

Q37287118-984B85E8-6C5A-44D1-BF28-E6ED3F998C3C

P1476

Q37287118-C49B75AB-D159-4C19-B2F6-CB99FA9824CF

P2093

Q37287118-0CC71A0B-3700-4A5F-92BE-6A13381240F3

Q37287118-75C62EED-7DA0-4ECD-A471-55B980B07D57

Q37287118-8AA66752-7301-468B-8AED-95CBCBBC9D5F

Q37287118-BF587844-2A8E-45BE-AEAB-5B1F8DD6F2DD

P2860

Q37287118-008EF606-9CA0-4EE7-B832-C54581CF44EA

Q37287118-0637DF1B-12D6-4735-97EC-F397B43814C8

Q37287118-0644AC81-21EF-45D2-B2B5-62C3186BA1DB

Q37287118-09BD8E44-15B9-4738-8D6E-797C2A9E212D

Q37287118-0EC5F8BD-E5C3-4B3C-A925-5F451D694F7A

Q37287118-0FE01E94-5910-471D-BCC5-1B3D36ACD0EB

Q37287118-103AC670-854C-46D8-A5D5-BE978D51219B

Q37287118-105AD784-8827-4F74-9F9C-F28B58A1FFAD

Q37287118-1188AE20-B6CC-479B-BBB8-E504A7A06158

Q37287118-11B7D0E5-D8E5-4B65-8B7D-5041BA449B36

P304

Q37287118-0F3A3C19-28BB-487C-8782-1CE526C6B5BA

P31

Q37287118-DC31A569-B839-4FFB-AA70-99828BF497AA

P356

Q37287118-1CF3B3C2-DBBC-48B7-B04F-802A6059ED1C

P433

Q37287118-28341197-811D-4972-8966-6F426C7DCAB2

P478

Q37287118-9AF2529A-C4C3-465A-8C4D-A2A62D7D4518

P577

Q37287118-7C8C1723-9D04-4AE9-A9F5-CD728C9AFB3D

P5875

Q37287118-D75ED071-EAE6-4023-AD5E-264DB4790DB0

P698

Q37287118-F538AE05-B5C5-4C4E-AFBF-CBB1A9570BF6

P921

Q37287118-BDB2C105-F5EC-48D6-9D75-4D5C3E24410D

P932

Q37287118-51A2C203-2E53-43F1-B955-90B5E78EF464

P356

157488909787002573

P1433

Recent patents on CNS drug discovery

P1476

Advances in oncolytic virus therapy for glioma.

@en

P2093

Abhik Ray Chaudhury

http://www.w3.org/2001/XMLSchema#string

Amy Haseley

http://www.w3.org/2001/XMLSchema#string

Balveen Kaur

http://www.w3.org/2001/XMLSchema#string

Christopher Alvarez-Breckenridge

http://www.w3.org/2001/XMLSchema#string

P2860

Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.

Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.

Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain.

Matrix metalloproteinases: a tail of a frog that became a prince.

Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.

P304

1-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/157488909787002573

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23796808

http://www.w3.org/2001/XMLSchema#string

P698

19149710

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

2720101

http://www.w3.org/2001/XMLSchema#string